Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

Tiriac, Hervé, Belleau, Pascal, Engle, Dannielle D., Plenker, Dennis, Deschênes, Astrid, Somerville, Tim D. D., Froeling, Fieke E. M., Burkhart, Richard A. +62 more·2018·Cancer Discovery

Cited by (1,001)

Items 801–900 of 1,001

  1. Progress of 3D Organoid Technology for Preclinical Investigations: Towards Human In Vitro Models
    Yingjuan Liu, Honglin Xu, Sabu Abraham, Xin Wang, Bernard D. Keavney · 2022 · International Journal of Drug Discovery and Pharmacology
  2. ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
    Nathan L. Tran, Jiewei Jiang, Min Ma, Gillian E. Gadbois, Kevin Christian Montecillo Gulay, Alyssa L. Verano, Haowen Zhou, Chun‐Teng Huang, David A. Scott, Anne G. Bang et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Developing biotechnologies in organoids for liver cancer
    Yi Hu, Zheng Peng, Mengdi Qiu, Lingling Xue, Haozhen Ren, Xingyu Wu, Xinhua Zhu, Yitao Ding · 2024 · Biomedical Technology
  4. Biomedical applications of organoids derived from the digestive system
    Zhensheng Xu, Zhongwen Lei, Qiuhua Cheng, Yuanhui Gao, Yang Xiang · 2025 · Frontiers in Cell and Developmental Biology
  5. Development of a novel PIK3CA-mutated pancreatic tumor mouse model and evaluation of the therapeutic effects of a PI3K inhibitor
    Yoshimasa Suzuki, Makoto Sugimori, Yushi Kanemaru, Sho Onodera, Hiromi Tsuchiya, Aya Ikeda, Ryosuke Ikeda, Yoshihiro Goda, Hiroaki Kaneko, Kuniyasu Irie et al. · 2025 · PLoS ONE
  6. Driving Precision Medicine in Pancreatic Cancer With Molecular Genetics
    Maria Farooq, Michael Jon Pishvaian · 2025 · Seminars in Radiation Oncology
  7. Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology
    Christopher Keßler, Francheska Cadacio, H. Carlo Maurer, Arlett Schäfer, Felix Orben, Julius Clemens Fischer, Daniela Schilling, Lisa Fricke, Sebastian Rasch, İhsan Ekin Demir et al. · 2025 · Translational Oncology
  8. Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived from saline flushes collected during routine EUS-FNA
    Tomoya Ekawa, Kenji Ikezawa, Yoji Kukita, Makiko Urabe, Yugo Kai, Ryoji Takada, Takashi Akazawa, Yu Mizote, Kumiko Tatsumi, Shigenori Nagata et al. · 2025 · Clinical & Translational Oncology
  9. Complementary strategies in pancreatic cancer precision medicine: therapeutic prediction and immune modulation
    Wonmin Lee, Hyun-Myung Woo, Ja Hyang Cho, Man Soo Kim · 2025 · Frontiers in Oncology
  10. Application and prospects of lung organ-on-a-chip in the development of new drugs
    Jun Su, Jingjing Qiu, Jiaxu Meng, Yi Gong, Yichun Xu, Junsong Han · 2025 · BioMedical Engineering OnLine
  11. Organoid-based systems for biomedical innovation: advances in disease modeling, drug screening, and precision medicine
    Aayush Prakash, Rishabha Malviya, Sathvik Belagodu Sridhar, Rashad Qasem Ali Othman, Anshoo Agarwal, Tarun Wadhwa, JAVEDH SHAREEF · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
  12. Patient-derived tumor organoids for new drug development: promises and challenges
    Meijun He, Ying Wu, Furong Du, Jingrui Wang, Honghan Zhang, Jian Han · 2026 · Investigational New Drugs
  13. ATP-binding cassette subfamily A member 5 suppresses pancreatic ductal adenocarcinoma progression and chemoresistance by promoting β-catenin ubiquitin-dependent degradation
    Zhenchong Li, Zuyi Ma, Yubin Chen, Weixuan Yu, Jiajie Yu, Jianmin Lu, Qiaoling Zhang, Qianlong Wu, Yifeng Cai, Zeyao Wang et al. · 2026 · Drug Resistance Updates
  14. Epigenetic Regulators as Therapeutic Targets in Pancreatic Ductal Adenocarcinoma
    Klaudia Kubiak, Iwona Inkielewicz‐Stępniak · 2026 · Cancers
  15. High-throughput generation of patient-derived cancer stem cells for precision medicine using a microwell-chip platform
    Zhe Zhao, Jie Wang, Xuan Xiong, Sheng Zhang, Mengdie Yang, H B Wu, Xingzhi Liu, Xinxing Ma, Yan Chen, Yong Qiao et al. · 2026 · Nature Cell Biology
  16. Emerging organoids and organoids-on-chip platforms for translational development of antibody‒drug conjugates and next-generation bioconjugates
    Zhuoliang Hu, Yuheng Liao, Mengxian Niu, Zhanghong Kong, Hugo E J Vankelecom, Jianjun Cheng, Michela Deleidi, Chenzhong Li, Zhengjin Jiang, Sumin Bian et al. · 2026 · Acta Pharmaceutica Sinica B
  17. Organoid technology in cancer research
    Jingjing Zhang, Jian He · 2026 · Molecular Biomedicine
  18. From structure to function: 3D tumor models for reconstructing tumor microenvironment regulatory networks and mechanical properties
    Mingke Wu, Dingjie Xu, Xuelin Dou, Yihan Zhou, Jin Lu, Qing Ge · 2026 · Cell Signaling Inflammation & Disease
  19. Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitis
    Victoria Osorio-Vasquez, Jonathan Zhu, Jan C. Lumibao, Kathryn Lande, Kristina L. Peck, McKenna K. Stamp, Shira R. Okhovat, Hyemin Song, Satoshi Ogawa, Casie S. Kubota et al. · 2026 · Cell stem cell
  20. Impact of ischemia on sample quality of human pancreatic tissues
    Junya Peng, Lulu Liu, Dan Huang, Hao Chen, Menghua Dai, Junchao Guo, Taiping Zhang, Quan Liao, Jialin Jiang, Wenze Wang et al. · 2019 · Pancreatology
  21. Oncolytic virotherapy meets the human organoid technology for pancreatic cancers
    Elena Fiorini, Vincenzo Corbo · 2020 · EBioMedicine
  22. The application and research advances of organoids in clinical medicine
    Shaobo Mo, Ruo‐Yu Guan, Zhang Long, Sanjun Cai, Junjie Peng, GuoQiang HUA · 2021 · Scientia Sinica Vitae
  23. Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
    Dora Barbosa Rabago, Collin Michael Blakely, Franziska Haderk, Trever Grant Bivona · 2021 · Journal of Visualized Experiments
  24. Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer
    Luke Wisniewski, Samuel Braak, Zachary L. Klamer, ChongFeng Gao, Chanjuan Shi, Peter J. Allen, Brian B. Haab · 2023 · Frontiers in Oncology
  25. Integrated procedures for accelerating, deepening, and leading genetic inquiry: A first application on human muscle secretome
    Danilo Bondi, Michele Bevere, Rosanna Piccirillo, Guglielmo Sorci, Valentina Di Felice, Andrea David Re Cecconi, Daniela C.S. Damico, Tiziana Pietrangelo, Stefania Fulle · 2023 · Molecular Genetics and Metabolism
  26. Improving gastrointestinal cancer therapy by uniting stakeholders
    Michael Quante, Anna Lena Saborowski, Christoph Benedikt Westphalen · 2024 · ESMO Gastrointestinal Oncology
  27. The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer
    Takaomi Hagi, Suwanna Vangveravong, Rony Takchi, Qingqing Gong, Simon Peter Goedegebuure, Hervé Tiriac, Brian Andrew Van Tine, Matthew A. Powell, William G. Hawkins, Dirk Spitzer · 2024 · Scientific Reports
  28. In-depth organoid profiling of pancreatic cancer
    Ju Eun Maeng, Ja‐Lok Ku · 2024 · Nature reviews. Cancer
  29. Endoscopic Tissue Sampling of Solid Pancreatic Lesions for Molecular Analysis
    Divya M. Chalikonda, Uzma D. Siddiqui · 2024 · Techniques and Innovations in Gastrointestinal Endoscopy
  30. Differential Effects of Confinement on the Dynamics of Normal and Tumor-Derived Pancreatic Ductal Organoids
    Jonah M. Rosas, Joseph P. Campanale, Jacob Harwood, Lufei Li, Rachel Bae, Shujun Cheng, Julia M. Tsou, Kathi M. Kaiser, Dannielle D. Engle, Denise J. Montell et al. · 2024 · ACS Applied Bio Materials
  31. Road Map to Defeat Pancreatic Cancer
    Lesley Paige Ferguson, David Arthur Tuveson · 2025 · Annual Review of Cancer Biology
  32. Current Organoid Culture Systems in Pancreatic Cancer
    Lei Liu, Jing Sun, Sheng Chen, Xuechan Tang, Shuai Zhang, Min Wang, Qian Yue, Changqing Zhong, Lianyong Li · 2025 · Current Topics in Medicinal Chemistry
  33. Novel Drug Screening Platform: Tumor Organoid
    Ju Eun Maeng, Ha‐Young Seo, Soon‐Chan Kim, Ja‐Lok Ku · 2021 · The Korean Journal of Pancreas and Biliary Tract
  34. Pancreatic plasticity: Unlocking exocrine lineage specification
    Jason Robert Pitarresi, Anil K. Rustgi · 2021 · Cell stem cell
  35. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
    Michael P. Kim, Matthew H. G. Katz · 2019 · Annals of Surgical Oncology
  36. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution
    Maria E. Monberg, Heather Geiger, Jaewon James Lee, Roshan Sharma, Alexander Semaan, Vincent Bernard, Daniel B. Swartzlander, Bret M. Stephens, Ken Chen, Matthew HG Katz et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoids
    Solange Le Blanc, Naveed Ishaque, Julia Jabs, Tobias Bauer, Sebastian Schuth, Qing Feng Hu, Olivia Debnath, Foo Wei Ten, Carl-Stephan Leonhardt, Anna‐Katharina König et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Patient-derived tumoroids of advanced high-grade neuroendocrine neoplasms mimic patient chemotherapy responses and guide the design of personalized combination therapies
    Simon April-Monn, Katharina M Detjen, Philipp Kirchner, Konstantin Bräutigam, Mafalda A. Trippel, Tobias J. Grob, Cyril Statzer, Renaud Maire, Attila Kollár, Aziz Chouchane et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Pancreatic cancer patient-derived organoids capture therapy response and tumor evolution
    Johann Gout, Lukas Perkhofer, Jessica Lindenmayer, Yazid J. Resheq, Julian D. Schwab, Johann Michael Kraus, Élodie Roger, Dharini Srinivasan, Eleni Zimmer, Benjamin Mayer et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Vascularized tumor organoids enable immunotherapy testing in tumor-remodeled stroma
    Reiner Wimmer, Rok Krese, Louisa Henniger, Steve Niu, Nadege Lagarde, Timon Keller, Inga Clausen, Fabian Köchel, Claudia Ferrara, Inja Waldhauer et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease
    Simona Dima, Traian Dumitraşcu, Irinel Popescu, Dan Gabriel Duda · 2022 · Chirurgia
  42. Ex-Vivo 3D Cellular Models of Pancreatic Ductal Adenocarcinoma
    Ivana Aćimović, Viktorie Gabrielová, Stanislava Martínková, Michal Eid, Jakub Vlažný, Petr Moravčík, Jan Hlavsa, Lukáš Moráň, Riza Can Cakmakci, Peter Staňo et al. · 2024 · Pancreas
  43. GATA6 Amplification Is Associated With Improved Survival in TP53-Mutated Unresectable Pancreatic Cancer
    Edward Zhou, Jung‐In Yang, Amber N. Habowski, Astrid Deschênes, Pascal Belleau, Taehoon Ha, Chris Tzanavaris, Jeff A. Boyd, Christopher Hollweg, Xinhua Zhu et al. · 2024 · Pancreas
  44. Global status of research on quality of life in pancreatic cancer patients: A bibliometric and network analysis from 2005-2024
    Adeboye Azeez, Colin Byron Noel · 2025 · Clinics and Research in Hepatology and Gastroenterology
  45. Cellulose microfiber-mediated mesoscale architecture promotes the expansion of patient-derived lung cancer organoids while preserving their malignant characteristics
    Chengjing Zhou, Jiaxin Wang, Yongming Zhang, Ziyuan Zhou, Chuanyue Wu, Lühua Wang, Ling Guo · 2025 · Journal of Materials Chemistry B
  46. Patient-Derived Cancer Organoids: Standardized Protocols for Tumor Cell Isolation, Organoid Generation, and Serial Passaging Across Multiple Cancers
    Ali Şahin, Dila Sener-Akcora, Ayşe Mine Yılmaz, Muharrem Okan Çakır, Betul Karademir-Yilmaz · 2025 · Methods in molecular biology
  47. EAP: A versatile cloud-based platform for efficient quantitative analysis of large-scale ChIP/ATAC-seq datasets
    Guangyong Zheng, Hao-Jie Chen, Zhijie Guo, Liang-Xiao Ma, Anqin Zheng, Tao Huang, Wei-Ran Chen, Shiqi Tu, Yi-Xue Li, Zhen-Yu Shao · 2025 · Computational and Structural Biotechnology Journal
  48. Quantitative assessment of nanoparticle uptake and trafficking in advanced 3D cell models: A high-content screening core to enhance precision nanomedicine development
    Meritxell B. Cutrona · 2025 · Methods in cell biology
  49. New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer
    Christoph Springfeld, Thilo Hackert, Daniel H. Palmer, Daniel Öhlund, Teresa Peccerella, Thomas P. Hank, Markus Wolfgang Büchler, Christoph W. Michalski, John P. Neoptolemos · 2025 · British Journal of Cancer
  50. The pancreatic cancer models helping to drive innovation in the field
    Rachel Nuwer · 2025 · Nature
  51. Construction and application of pancreatic exocrine organoid and spheroid for drug screening and precision medicine
    Xin Tan, Bangwei Huang, Xinyi Yang, Peng‐Yuan Wang, Lianghao Hu · 2026 · Frontiers in Cell and Developmental Biology
  52. Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies
    Caitlin Tsang, Hardik Patel, Fatim M. Kouassi, Binny Khandakar, Luce St. Surin, James A. Rouse, Raditya Utama, Deepthi Poornima Budagavi, Julien T. Hohenleitner, Adeline Chunton et al. · 2026 · The Journal of Pathology
  53. FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer
    Deblina Ghosh, Aslamuzzaman Kazi, Hitesh Kumar Kantilal Vasiyani, Vignesh Vudatha, Nicolas Lecomte, Christine A. Iacobuzio–Donahue, Jose Trevino, Said M. Sebti · 2026 · European Journal of Cancer
  54. AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organoids
    Emma Wen, Catalina Vera, Sahaana Kesavan, Fatim M. Kouassi, Joseph F. LaComb, Neecki Zand, David Arthur Tuveson, Amber N. Habowski, Antonio T. Baines, Agnieszka B. Bialkowska · 2026 · Frontiers in Pharmacology
  55. Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types
    Yaya Yu, Yanan Li, Jiao Wang, Yan-juan Zhu, Zexin Zhang, Zhenzhen Xiao, Yadong Chen, Yanchun Qu, Ling Han, Haibo Zhang · 2026 · Experimental Hematology and Oncology
  56. Hyaluronan-Based Glioblastoma Tumor Constructs Maintain Patient Tumor Drug Responses and Genomic Parity
    Hemamylammal Sivakumar, Steven Donald Forsythe, Adrian W. Laxton, Stephen B. Tatter, Lance David Miller, Roy Ervin Strowd III, Aleksander Skardal · 2026 · Micromachines
  57. MondoA mediates transcriptional coordination between the MYC network and the integrated stress response in pancreatic cancer
    Erin L. Ramsey, Stephanie Dobersch, Brian W. Freie, Nan Hyung Hong, Xiaoying Wu, Sita Kugel, Robert N. Eisenman, Patrick A. Carroll · 2026 · Proceedings of the National Academy of Sciences
  58. Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer
    Ye Jin Moon, Woo Sun Kwon, C. B. Park, Jinsoo Jang, Juin Park, Byeong Gyu Yoon, Han Byeol Mun, Namju Kim, Choong‐kun Lee, Hei‐Cheul Jeung et al. · 2026 · Journal of the Korean Gastric Cancer Association
  59. Fatty Acid Synthase (FASN) as a targeted therapeutic in acquired 5-fluorouracil resistance in pancreatic cancer
    Sara Noorani, Rían Ó Madáin, Jojanneke Stoof, Elodie Lepeltier, Esen Efeoğlu, Michael Henry, Paula Meleady, Tia E. Keyes, Naomi Walsh · 2026 · Biomedicine & Pharmacotherapy
  60. Organoid models: reshaping the paradigm for precision development and evaluation of CAR-T cell therapies
    Haipeng Li, Jiaqi Yan, Yuxi Liu, Xunqian Tao, Keying Guo, Jing Zhang · 2026 · Frontiers in Bioengineering and Biotechnology
  61. Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targets
    Divya Murthy, Attila A. Seyhan, Petra den Hollander, Shaolei Lu, Nick Allen Kuburich, Claire Gould, Andrew Karam, Katie Sun, Patrick G. Schupp, Howard Safran et al. · 2026 · Molecular Aspects of Medicine
  62. ASO-based PKM splice-switching therapy increases anti-CTLA-4 antibody efficacy in pancreatic ductal adenocarcinoma
    Lijie Han, Lina Gan, Balázs Schäfer, Dillon M. Voss, Mathias Bogetoft Danielsen, Ondřej Kostov, Jia Liu, Ting Wang, Marvin H. Caruthers, Hao Chen et al. · 2026 · Cell Discovery
  63. Progress and challenges in the development of advanced pancreatic cancer organoids
    Katja Detert, Alban Piotrowsky, Luigi Marongiu, Christian Leischner, Ulrich M. Lauer, Sascha Venturelli, Markus Burkard · 2026 · Journal of Experimental & Clinical Cancer Research
  64. Gastric Cancer Organoids: Mechanistic Insights, Drug Discovery, and Translational Advances in Precision Medicine
    Na Liu, Yan Zhang, Yao Liu, Xiao Dong, Y D Li, Jinrui Geng, Yonghong Li · 2026 · Journal of the Korean Gastric Cancer Association
  65. Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLC
    Enrique Podaza, Jared A. Capuano, Hui–Hsuan Kuo, Majd Al Assaad, Geoffrey J. Markowitz, Maria Victoria Revuelta, John Nguyen, Adriana Irizarry, Hiranmayi Ravichandran, Sarah Ackermann et al. · 2026 · Cell Reports Methods
  66. Patient-Derived Organoids in Clinical Medicine: Proven Impact and Future Directions
    Magdalena Skowrońska, Ece Yıldız, Jens Grosch, Mairene Coto‐Llerena · 2026 · Organoids
  67. Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts
    Anuja Lipsa, Gaëlle Triballier, Anna Golebiewska · 2026 · Seminars in Cancer Biology
  68. A Pan-Cancer Preclinical Validation Framework for Organoid-Based Drug Sensitivity Testing
    Jia Shang, Caixia Xia, Zilin Xu, Sheng Tu, Gang Li, Fangjin Chen, Lingao Ju, Gang Wang, Yu Xiao, Kaiyu Qian · 2026 · Organoids
  69. Intra-Tumor Heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC)—Microenvironmental Interaction and Precision Immunotherapy Strategies: A Multi-Omics-Based Integrated Perspective
    Boyeon Kim, J.H. Lee · 2026 · International Journal of Molecular Sciences
  70. Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities
    Hui–Hsuan Kuo, Bhavneet Bhinder, Hamza Numan Gokozan, Kathryn Gorski, Pooja Chandra, Jyothi Manohar, Daniela E. Guevara, John R. Otilano, Jenna E. Moyer, Marvel Tranquille et al. · 2026 · Science Advances
  71. Integrated Screening Cascades for Ion-Channel Drug Discovery: Linking Structure, Electrophysiology, Safety Pharmacology, and Human-Relevant Models
    Yohan Seo · 2026 · International Journal of Molecular Sciences
  72. Decoding drug resistance and apoptosis in biliary tract cancers using 3D tumor models
    Gurpreet Singh Gill, Om Saswat Sahoo, Arnab Nayek, Sajib Kumar Sarkar, Kailash Chand Kurdia, Nidhi Bhardwaj, Chandan J. Das, Saurabh Galodha, Gitanjali Goyal, Subhradip Karmakar et al. · 2026 · Frontiers in Cell Death
  73. Patient-derived organoids in functional precision oncology: from experimental models to clinical decision-making
    Amanda Caruso, Antonella Delvecchio, Riccardo Memeo, Marilena Lanzino, S Martinotti · 2026 · Frontiers in Endocrinology
  74. Construction Strategies, Microenvironmental Modelling and Precision-Therapy Applications of Glioma Organoid Models
    Songming Chen, Wei Zhang, Luohuan Dai, Yubin Kuang, Haodi Yang, Jia Gu, Kang Peng, Nian Jiang, Hongwei Liu, Xuejun Li · 2026 · Cancers
  75. Biofabrication and artificial intelligence strategies for investigating solid- and fluid-pressure mechanobiology in pancreatic ductal adenocarcinoma
    Yahui Ding, Peiyuan Zhao, Jin Yan, Yan Li, Zifei Wang, Ye Lu, Yichen Zhang, Hongzhuan Chen, Weidong Zhang, Xin Luan et al. · 2026 · Cancer and Metastasis Reviews
  76. Dual-oxygen pancreatic cancer organoids recapitulate basal–classical heterogeneity validated by spatial transcriptomics
    Koichiro Kumano, Hiromitsu Nakahashi, Osamu Shimomura, Yoshimasa Akashi, Yoshihiro Miyazaki, Yohei Owada, Shinji Hashimoto, Kazuto Kamohara, Shuhei Komatsuzaki, Yukihito Kuroda et al. · 2026 · British Journal of Cancer
  77. Induced pluripotent stem cells from discovery to translation
    Jaecheol Lee, Todd J. Herron, Lorenz Studer, Christine L. Mummery, Joseph C. Wu · 2026 · Nature Medicine
  78. A Presynaptic Protein Is a Net Gain for Pancreatic Tumor Progression
    Mara H. Sherman · 2021 · Cancer Discovery
  79. Emphasis on Organoids in Cancer Research
    Kartiki Bhandari, Rupali Patil, Prashant Pingale, Sunil Vishwanath Amrutkar · 2021 · Cancer and Oncology Research
  80. Early Cell Cultures from Prostate Cancer Tissue Express Tissue Specific Epithelial and Cancer Markers
    Vladimir Ryabov, Mikhail Baryshev, M. A. Voskresenskiy, Boris V. Popov · 2023 · International Journal of Molecular Sciences
  81. Tumor Ecosystem-Mimicking Bioengineering Methods
    Phei Er Saw, Erwei Song · 2023 · Springer eBooks
  82. Pathology of Digestive System Malignancies
    Ioannis Parthymos, Redi Bumci, ANNA C. GOUSSIA · 2023 · Springer eBooks
  83. Widespread alteration of protein autoinhibition in human cancers
    Jorge A. Holguin-Cruz, Jennifer M. Bui, Ashwani Jha, Dokyun Na, Jörg A. Gsponer · 2024 · Cell Systems
  84. Deciphering of SOX9 Functions in Pancreatic Cancer Cells
    К. Н. Кашкин, Liya G. Kondratyeva, E. P. Kopantzev, Ivan S. Abramov, Lyudmila Zhukova, И. П. Чернов · 2025 · International Journal of Molecular Sciences
  85. Bringing Pancreas Cancer into the Lab
    Eric Andrew Collisson · 2018 · Cancer Discovery
  86. Practical Applications of 3D Cell Culture Biotechnologies for Translational Oncology and Personalized Therapy
    Daria A. Chudakova, E. Skorova, Игорь Владимирович Решетов · 2020 · Biotekhnologiya
  87. PDAC Subtypes/Stratification
    Holly Brunton, Giuseppina Caligiuri, Gareth J. Inman, Peter J. Bailey · 2020 · Molecular and translational medicine
  88. The Evolution of Adjuvant Trials in Pancreatic Cancer
    John P. Neoptolemos, Christoph Springfeld, Thilo Hackert, Markus Wolfgang Büchler · 2021 · Springer eBooks
  89. Precision medicine in a dish
    Amaia Lujambio · 2018 · Science Translational Medicine
  90. Desenvolvimento de xenotransplantes de tumores pancreáticos humanos para varredura genética de alvos moleculares com potencial terapêutico
    Luis Bruno da Cruz e Alves de Moraes · 2019
  91. Putting the Cell of Origin for Pancreatic Cancer Into its Proper Context
    Howard C. Crawford · 2019 · Cellular and Molecular Gastroenterology and Hepatology
  92. Functional drug susceptibility testing based on biophysical measurements predicts patient outcome in glioblastoma patient-derived neurosphere models
    Max A. Stockslager, Seth W. Malinowski, Mehdi Touat, Jennifer C. Yoon, Jack E. Geduldig, Mahnoor Mirza, Annette S. Kim, Patrick Yung Wen, Kin-Hoe Chow, Keith Lloyd Ligon et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Detection of incipient pancreatic cancer with novel tumor-specific antibodies in mouse models
    Tobiloba E. Oni, Carmelita Bautista, Joseph R. Merrill, Jeroen A. C. M. Goos, Keith D. Rivera, Koji Miyabayashi, Giulia Biffi, Libia A. Garcia, Dennis Plenker, Hardik Patel et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  94. A cancer cell-intrinsic GOT2-PPARδ axis suppresses antitumor immunity
    Hannah S. Sanford-Crane, Jaime Abrego, Chet Huan Oon, Xiao Xu, Shanthi Nagarajan, Sohinee Bhattacharyya, Peter Tontonoz, Mara H. Sherman · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Staging Classification and Stratification of Pancreatic Cancer for Clinical Practice
    Akhil Chawla, Andrew J. Aguirre · 2021
  96. NPEPPS is a novel and druggable driver of platinum resistance
    Robert T. Jones, Mathijs Scholtes, Andrew E. Goodspeed, Maryam Akbarzadeh, Saswat Mohapatra, Lily Elizabeth Feldman, Hedvig Vékony, Annie Jean, Charlene B. Tilton, Michael V. Orman et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Complete remission in a patient with widely metastatic HER2-amplified pancreatic adenocarcinoma following multimodal therapy informed by tumor sequencing and organoid profiling
    Daniel A. King, Amber Rae Smith, Gino Pineda, Michitaka Nakano, Flavia Michelini, Simon Peter Goedegebuure, Sheeno P. Thyparambil, Wei‐Li Liao, Aaron K. McCormick, Jihang Ju et al. · 2021 · medRxiv
  98. The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response—Response
    Henry C.-H. Law, Emalie J. Clement, Paul M. Grandgenett, Michael Anthony Hollingsworth, Nicholas T. Woods · 2021 · Clinical Cancer Research
  99. Preclinical Screening of Splice-Switching Antisense Oligonucleotides in PDAC Organoids
    Ledong Wan, Alexander J. Kral, Dillon M. Voss, Adrian R. Krainer · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  100. p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma
    Stella K. Hur, Tim D.D. Somerville, Xiaoli Wu, Diogo Maia-Silva, Osama E. Demerdash, David Arthur Tuveson, Faiyaz Notta, Christopher R. Vakoc · 2023 · bioRxiv (Cold Spring Harbor Laboratory)